Singapore, March 23 -- Brandon BioCatalyst, in partnership with ANDHealth, has been selected by the Federal Government to deliver the $50 million BioMedTech Incubator (BMTI) programme. The investment, from the $20 billion Medical Research Future fund (MRFF) in Australia, substantially increases the grant funding available through existing Brandon BioCatalyst and ANDHealth programmes to more than $115 million.

The BMTI programme will leverage the highly specialised selection, assessment and growth capabilities which have been built through CUREator, the Brandon BioCatalyst managed national biotech incubator, and ANDHealth+, the ANDHealth managed national digital health accelerator.

The new BMTI programme, which commences later this year,...